|
Market Closed -
Toronto S.E.
03:50:47 2026-10-28 pm EDT
|
5-day change | 1st Jan Change | ||
| 32.06 CAD | +0.34% |
|
+3.22% | +26.77% |
| Oct. 28 | Calendar Thursday, October 29 | FW |
| Oct. 27 | Gilead Sciences Inc Announces National Agreement for LYVDELZI Seladelpar for Primary Biliary Cholangitis in Canada | CI |
| Market Cap | 197B 177B 164B 148B 277B 18,801B 280B 1,958B 780B 9,838B 741B 725B 31,232B | P/E 2026 * |
-45.8x | P/E 2027 * | 19.7x |
|---|---|---|---|---|---|
| Enterprise Value | 219B 196B 181B 164B 307B 20,827B 311B 2,169B 864B 10,898B 821B 803B 34,598B | EV / Sales 2026 * |
7.11x | EV / Sales 2027 * | 6.42x |
| Free-Float |
99.89% | Yield 2026 * |
2.07% | Yield 2027 * | 2.11% |
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| GILD | Delayed | |
Deutsche Boerse AG
| GIS0 | Delayed |
Last Transcript: Gilead Sciences, Inc.
| 1 day | +0.34% | ||
| 1 week | +3.22% | ||
| Current month | +6.65% | ||
| 1 month | +4.57% | ||
| 3 months | +18.04% | ||
| 6 months | +21.21% | ||
| Current year | +26.77% |
| 1 week | 31.41 |  | 32.08 |
| 1 month | 28.94 | | 32.18 |
| Current year | 23.97 | | 32.18 |
| 1 year | 23.62 | | 32.18 |
| 3 years | 20.08 | | 32.18 |
| 5 years | 20.08 | | 32.18 |
| 10 years | 20.08 | | 32.18 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 61 | 2019-02-28 |
Andrew Dickinson
DFI | Director of Finance/CFO | 56 | 2019-10-31 |
Keeley Wettan
CMP | Compliance Officer | - | 2025-12-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Kelly Kramer
BRD | Director/Board Member | 58 | 2016-08-18 |
| Director/Board Member | 73 | 2017-12-31 | |
Harish Manwani
BRD | Director/Board Member | 72 | 2018-05-08 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.34% | +3.22% | - | - | 197B | |
| +0.50% | +1.38% | +57.09% | +129.96% | 1,143B | |
| +0.86% | +5.14% | +45.00% | +86.15% | 647B | |
| -0.14% | +0.42% | +25.69% | +105.85% | 506B | |
| -0.05% | +1.73% | +52.74% | +67.74% | 384B | |
| -0.63% | -5.97% | +61.93% | +37.06% | 350B | |
| +0.34% | +1.84% | +30.70% | +54.27% | 293B | |
| -0.45% | +1.19% | +2.89% | +26.08% | 265B | |
| +0.87% | +3.08% | +54.69% | +72.74% | 242B | |
| +0.08% | +3.67% | +35.05% | +107.78% | 197B | |
| Average | +0.17% | +0.85% | +40.64% | +76.40% | 447.5B | |
| Weighted average by Cap. | +0.26% | +0.71% | +44.50% | +89.02% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 30.77B 27.61B 25.52B 23.12B 43.19B 2,930B 43.71B 305B 122B 1,533B 115B 113B 4,868B | 32.89B 29.51B 27.28B 24.71B 46.16B 3,132B 46.72B 326B 130B 1,639B 123B 121B 5,203B |
| Net income | -4.38B -3.93B -3.63B -3.29B -6.14B -417B -6.22B -43.39B -17.28B -218B -16.42B -16.07B -692B | 10.28B 9.23B 8.53B 7.72B 14.43B 979B 14.61B 102B 40.62B 512B 38.58B 37.77B 1,627B |
| Net Debt | 21.27B 19.09B 17.65B 15.98B 29.86B 2,026B 30.22B 211B 84.03B 1,060B 79.83B 78.14B 3,366B | 13.62B 12.22B 11.3B 10.23B 19.12B 1,297B 19.35B 135B 53.8B 679B 51.11B 50.03B 2,155B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-28 | CA$32.06 | +0.34% | 3,090 |
| 26-10-27 | CA$31.95 | +0.09% | 4,698 |
| 26-10-26 | CA$31.92 | +1.62% | 4,943 |
| 26-10-23 | CA$31.41 | -0.66% | 1,305 |
| 26-10-22 | CA$31.62 | +1.80% | 15,559 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GILD Stock
- GILD Stock
Select your edition
All financial news and data tailored to specific country editions
